Table 5. Antihypertensive drug classes and combinations according to BP control status.
| CLASSES OF ANTIHYPERTENSIVE MEDICATIONS | Blood pressure <140/90mmHg N = 1,213 |
Blood pressure >140/90mmHg N = 1,657 |
Total N = 2870 |
P-values |
|---|---|---|---|---|
| Angiotensin Converting Enzyme Inhibitors | 476 (39.2) | 763 (46.0) | 1239 (43.2) | 0.0003 |
| Angiotensin Receptor Blockers | 312 (25.7) | 472 (28.5) | 784 (27.3) | 0.10 |
| Beta blockers | 91 (7.5) | 189 (11.4) | 280 (9.8) | 0.0005 |
| Calcium Channel Blockers | 961 (79.2) | 1398 (84.4) | 2359 (82.2) | 0.0004 |
| Diuretics | 342 (28.2) | 498 (30.1) | 840 (26.3) | 0.28 |
| Centrally acting vasodilators (Methyldopa) | 116 (9.6) | 282 (17.0) | 398 (13.9) | <0.0001 |
| Peripheral vasodilators (Hydrallazine) | 7 (0.6) | 35 (2.1) | 42 (1.5) | 0.0007 |
| NUMBER OF ANTIHYPERTENSIVE MEDICATIONS | ||||
| <0.0001 | ||||
| 1 | 308 (25.4) | 275 (16.6) | 583 (20.3) | |
| 2 | 560 (46.2) | 772 (46.6) | 1332 (46.4) | |
| 3 | 220 (18.1) | 429 (25.9) | 649 (22.6) | |
| 4 | 43 (3.5) | 107 (6.5) | 150 (5.2) | |
| 5 | 9 (0.7) | 18 (1.1) | 27 (0.9) | |
| 6 | 0 (0.0) | 1 (0.1) | 1 (0.0) | |
| 7 | 0 (0.0) | 1 (0.1) | 1 (0.0) | |
| No data available | 73 (6.0) | 54 (3.3) | 127 (4.4) | |
| Mean ± SD | 1.90 ± 0.94 | 2.20 ± 0.95 | 2.07 ± 0.95 | <0.0001 |
| Median (IQR) | 2 (1–2) | 2 (2–3) | 2 (2–3) | <0.0001 |